VICENZA, Italy, November 15, 2016 /PRNewswire/ -- Theleadingcompanyin the laser therapy research and productionfieldsigns an agreementat the China-Italy Innovation Forumwith two Chinese players forthetech and healthcaresectors in orderto develop specific protocols to apply MLS® Laser Therapy to acupuncture points.ASAlaser is looking with growing interest towards China, thanks to the agreement signed with Beijing TED Healthcare Technology Ltd. and the Beijing Hospital of Traditional Chinese Medicine. The three companies will collaborate in order to develop protocols aimed at employing MLS® Laser Therapy - one of the top ASAlaser therapies - in the field of laser puncture. One single goal: to find new therapeutic solutions to efficiently treat multiple pathologies, first and foremost those which cause non-specific musculo-skeletal pain. (Photo: http://photos.prnewswire.com/prnh/20161111/438345 ) (Logo: http://photos.prnewswire.com/prnh/20150724/242098LOGO ) This new goal achieved by ASAlaser, for more than 30 years in the front line for the research and production of laser therapies for physiotherapy and rehabilitation, took place against the background of the China-Italy Science, Technology & Innovation Week (25/27 October), a world-class matchmaking event addressed to businesses, universities, research centres and public bodies of the two countries, which also aims to promote business opportunities. In fact, through a schedule structured on science, technology and innovation themes and based on B2B meetings, Italian and Chinese operators were able to meet face to face, thereby strengthening growth relationships and reinforcing the economic co-operation already in place. The 2016 edition, promoted by MIUR, co-ordinated by Città della Scienza in collaboration with CNR and structured in three locations (Bergamo 25/10, Bologna 26/10 and Naples 26-27/10), allowed ASAlaser, which is currently present with its own therapeutic solutions in over 80 countries spread across 5 continents, to take a further step forward along its internationalisation process. The value of the two therapies was underlined during seminars held at the China-Italy Innovation Forum in Napoli by the ASAlaser Chairman Lucio Zaghetto, by the Managing Director of Beijing TED Healthcare Technology Ltd. - Dai Rujun - and by Wang Linpeng, the director of the Acup-center of the Beijing Hospital of Traditional Chinese Medicine. The acupuncture expert pointed out that the "integration with the technological innovation which characterises ASAlaser can be considered the new frontier which this important sector of traditional Chinese medicine strives towards".